ArticleIndian journal of pediatrics2025
Epidemiology and Management of Intussusception Among Children Aged Under 2 Years in Gujarat, India.
Article in Indian journal of pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
objectivesSome rotavirus vaccines are associated with an increased risk of intussusception (IS) in children. This study investigated the epidemiology of IS in children aged under 2 y in Gujarat, India.
methodsHospital-based surveillance of IS cases was conducted from July 2019 to December 2022 at four hospitals in Gujarat. Children aged under 2 y who met the level 1 Brighton criteria were enrolled. Data were collected on their sociodemographic and clinical characteristics, clinical management, feeding patterns, and immunization history.
resultsOverall, 213 children with IS were enrolled. Their median age was 8 (interquartile range, 6-13) mo and 62.9% were boys. No seasonal variation in the incidence of IS was observed. The most common presenting complaints were vomiting (82.6%), abdominal pain (76.1%), and bloody stools (53%). Most cases (56.3%) were managed via radiological reduction; 21.6% underwent exploratory laparotomy and intra-operative reduction; 10.3% underwent bowel resection; and 11.7% were treated using mixed modalities. Children admitted more than 48 h after the onset were significantly more likely to require surgical intervention (33% vs. 17.9%, p = 0.002) and have hospital stays > 5 d (59% vs. 35.2%, p < 0.001). In total, 13 of 169 children with documented rotavirus vaccination had received a dose of rotavirus vaccine within 21 d of the onset of symptoms.
conclusionsOngoing surveillance is needed to establish whether vaccination with the oral pentavalent rotavirus vaccine, ROTASIIL, is associated with an increased risk of IS. Early case detection and referral, and increased use of safe and non-surgical methods of treatment need to be encouraged.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.